Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Low-Dose Growth Hormone: Effective for Reducing Abdominal Fat, but Questions Remain
In a clinical trial conducted among HIV-infected patients with increased abdominal fat and relative growth-hormone (GH) deficiency, an 18-month course of low-dose GH reduced visceral and trunk obesity but increased glucose intolerance.
Sign In
Don't yet have a username or password?
Register now for
Journal Watch e-mail alerts and unlimited online
access to articles 6 months after publication.
Subscribe now for
Full, immediate online access to all Journal Watch content and services.
Already a subscriber? Activate your subscription to receive full online access.
Get full site access with a 7-day site pass for $19